Thyroid storm is tumultuous and exciting; Myxedema is somewhat enervating and markedly less exciting–but it is also life threatening. We need to know about this disease! Today, I interview Arti Bhan, MD on the topic:
Arti Bhan, MD
Division Head, Endocrinology @HenryFord Health System
“I strive to provide the highest quality health care services to all my patients efficiently, effectively and compassionately. I believe in partnering with my patient in order to achieve our goals.”
Dr. Bhan received her medical degree from India. She completed an Internal Medicine Residency at St. John Hospital and Medical Center and then went on to a fellowship in Endocrinology at Henry Ford Health System.
She has been a senior staff physician at Henry Ford since 2003 and is currently serving as the Division Head of Endocrinology. She is active in clinical research and is an investigator in numerous trials, including NIH funded studies. She is published in peer reviewed literature and is the Associate Editor for Clinical Diabetes.
Dr. Bhan's main area of interest is in thyroid disorders, and she trains fellows in thyroid ultrasonography and thyroid biopsies.
What We Cover on Myxedema
- What is the look of myxedema
- What TSH should get you worried
- How to treat Myxedema
- Should we use T3 (LT3)
- What do resus docs screw up when treating myxedema
Related & More
Now on to the Podcast…
- EMCrit 293 – The Jerk & Check, Functional Heuristics in Resuscitation Project (MotR) - March 3, 2021
- EMCrit 292 – IV T3 for Myxedema Coma, A Different Take with Eve Bloomgarden - February 23, 2021
- EMCrit 291 – For Frak's Sake, Ketamine is at least as Hemodynamically Stable as Etomidate! - February 9, 2021